Transgenic expression of IL-33 activates CD8(+) T cells and NK cells and inhibits tumor growth and metastasis in mice.
about
IL-33 signaling is essential to attenuate viral-induced encephalitis development by downregulating iNOS expression in the central nervous systemAnti-asialo GM1 NK cell depleting antibody does not alter the development of bleomycin induced pulmonary fibrosis.Interleukin 33: a switch-hitting cytokine.Tumoral expression of IL-33 inhibits tumor growth and modifies the tumor microenvironment through CD8+ T and NK cellsVascular dysfunction and increased metastasis of B16F10 melanomas in Shb deficient mice as compared with their wild type counterparts.Interleukin 33 in tumor microenvironment is crucial for the accumulation and function of myeloid-derived suppressor cells.The PDGF-BB-SOX7 axis-modulated IL-33 in pericytes and stromal cells promotes metastasis through tumour-associated macrophagesDeletion of IL-33R attenuates VEGF expression and enhances necrosis in mammary carcinoma.Soluble IL-33 receptor sST2 inhibits colorectal cancer malignant growth by modifying the tumour microenvironmentExogenous IL-33 overcomes T cell tolerance in murine acute myeloid leukemia.Significance of interleukin-33 and its related cytokines in patients with breast cancers.Intratumorally Establishing Type 2 Innate Lymphoid Cells Blocks Tumor Growth.Interleukin-33 in tumorigenesis, tumor immune evasion, and cancer immunotherapy.IL-33 promotes growth and liver metastasis of colorectal cancer in mice by remodeling the tumor microenvironment and inducing angiogenesis.Interleukin 33: an innate alarm for adaptive responses beyond Th2 immunity-emerging roles in obesity, intestinal inflammation, and cancer.Interleukin-33/ST2 axis promotes breast cancer growth and metastases by facilitating intratumoral accumulation of immunosuppressive and innate lymphoid cells.Interleukin-33 in human gliomas: Expression and prognostic significance.IL-33 restricts tumor growth and inhibits pulmonary metastasis in melanoma-bearing mice through eosinophils.Interleukin-33 promoting Th1 lymphocyte differentiation dependents on IL-12.Interleukin-33 predicts poor prognosis and promotes ovarian cancer cell growth and metastasis through regulating ERK and JNK signaling pathways.Epithelial-derived IL-33 promotes intestinal tumorigenesis in Apc Min/+ mice.Critical role of IL-33 receptor ST2 in experimental cerebral malaria development.IL-33 released by alum is responsible for early cytokine production and has adjuvant properties.IL-33 blockade suppresses tumor growth of human lung cancer through direct and indirect pathways in a preclinical model.IL-33 inhibits the differentiation and immunosuppressive activity of granulocytic myeloid-derived suppressor cells in tumor-bearing mice.IL‑33 enhances glioma cell migration and invasion by upregulation of MMP2 and MMP9 via the ST2-NF-κB pathway.Exogenous IL-33 Restores Dendritic Cell Activation and Maturation in Established Cancer.Alarmins and immunity.A novel mechanism of tumor-induced thymic atrophy in mice bearing H22 hepatocellular carcinoma.Characterization and allergic role of IL-33-induced neutrophil polarization.Integrated Expression Profiles Analysis Reveals Correlations Between the IL-33/ST2 Axis and CD8+ T Cells, Regulatory T Cells, and Myeloid-Derived Suppressor Cells in Soft Tissue Sarcoma.Lower expression level of IL-33 is associated with poor prognosis of pulmonary adenocarcinoma.The Pro-tumorigenic IL-33 Involved in Antitumor Immunity: A Yin and Yang CytokineThe Role of IL-33/ST2 Pathway in Tumorigenesis
P2860
Q26700067-D5E62DAF-C5D1-4811-85FC-EDBFC6D287D6Q33748545-14F7B695-7860-4352-AB14-B2AD3832DBD3Q33987547-B065EA45-4615-4EB0-8249-E084C65D123DQ34749359-7E0B3B88-A4B6-4E8F-A903-DEBE0667EA71Q35358884-2CB9300E-98A8-4528-A5A8-85BC90A1F40FQ36597506-99A317E0-A648-40B6-AE43-F2EB9EC45F45Q36876563-903BF4B9-3217-43F5-A0F4-6B567BE309C3Q37109698-D3EB6ED7-CB57-4A9A-8030-EF531DAFABD5Q37439634-232C9A0F-71F2-4456-9195-FFC851D76709Q37641560-F2929AA1-1154-446A-981F-7AADBD5376CCQ37700227-BCBE643F-608A-4CFC-B96A-B7700986FC4FQ38417709-0640FEA9-8FFA-4A75-9C83-564E8014F0B2Q38753216-243EF758-DD08-40B4-B5D2-CFAFFB8490A8Q38775054-0A62F88D-4DE2-4172-975D-132BA5342BE6Q38783993-F5EA0037-3AE3-4F8A-8415-73DAFD6CD65AQ39084378-DDCAD692-DD69-44D1-B002-A808905B036FQ39653025-86D34FD3-5077-4941-ACC0-42A1C25F2836Q40146282-0F50E3A5-3BFC-4E5A-B637-E0DB9109EA04Q40187803-3AF821D7-61AB-4BF7-B0C0-B192806F4877Q40470696-60616A32-684B-4B0B-9542-E3F73EF3A30EQ41019883-04C925A5-9D65-4567-A229-22EA23CBBDE4Q41482873-662716B6-E11B-4659-811C-F895624E0666Q41842923-E9954AF6-3E9E-4EFB-A1B2-A78B3A4CBF19Q41972983-CB34B21B-9F3F-4762-BA4D-2B44CFFF6703Q46504021-C02D7385-313A-480C-A417-C1F190942959Q46866026-463098A6-395F-4747-B126-312266DF7530Q48120429-21703BF0-2DF4-4D66-88B6-8350FCE0C5ECQ48193695-53638BCC-9FDC-4FC7-B602-275BDA5A6A80Q52649899-74F3E449-BDD6-42EA-8C02-8ABA8B9755D4Q54982524-88570F29-AF03-4ED2-9340-F4A4E783233CQ55275991-0886D64F-E70E-4001-8C94-29DE09799EF7Q55373264-0C3EBF0C-99E8-416A-A167-D2675D9502DAQ58707724-CFC691FC-2356-4440-BF61-BCD9AFC8B90EQ58756972-EFBBAF22-1A35-4222-8C3E-1D6DD66190FB
P2860
Transgenic expression of IL-33 activates CD8(+) T cells and NK cells and inhibits tumor growth and metastasis in mice.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Transgenic expression of IL-33 activates CD8
@nl
Transgenic expression of IL-33 ...... growth and metastasis in mice.
@en
type
label
Transgenic expression of IL-33 activates CD8
@nl
Transgenic expression of IL-33 ...... growth and metastasis in mice.
@en
prefLabel
Transgenic expression of IL-33 activates CD8
@nl
Transgenic expression of IL-33 ...... growth and metastasis in mice.
@en
P2093
P1433
P1476
Transgenic expression of IL-33 ...... growth and metastasis in mice.
@en
P2093
Guiying Shi
Lianfeng Zhang
Lingying Wu
Xianzhu Xia
Xiaoying Li
P304
P356
10.1016/J.CANLET.2013.03.002
P407
P577
2013-03-14T00:00:00Z